In a mouse model of HCC, it has been shown that activation of Wnt/β-catenin signaling induces reduced migration of CD103+ DCs and CD8+ TIL deficiency via downregulation of CCL5. The gene discussed is CCL5; the disease is hepatocellular carcinoma.